Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

869.58
-43.1800-4.73%
Post-market: 867.75-1.8300-0.21%19:59 EST
Volume:4.82M
Turnover:4.22B
Market Cap:824.51B
PE:74.26
High:908.00
Open:905.39
Low:861.39
Close:912.76
Loading ...

Eli Lilly Introduces New Weight Loss Drug Doses, Lowers Price Points

Dow Jones
·
25 Feb

BUZZ-Lilly rises on launch of high-dose vials for its weight-loss drug

Reuters
·
25 Feb

Lilly Adds New Zepbound Doses; Lowers Prices for Self-Pay Patients

MT Newswires Live
·
25 Feb

Eli Lilly Shares up 1.8% Premarket After Co Launches Higher Dose Vials of Weight-Loss Drug for $150 Less Than Injector Pen

THOMSON REUTERS
·
25 Feb

Eli Lilly To Cut Zepbound Single-Dose Vials To $499 A Month From $699 Previously -- MarketWatch

Dow Jones
·
25 Feb

Lilly Launches Additional Zepbound Vial Doses and Offers New Savings for Self-Pay Patients

THOMSON REUTERS
·
25 Feb

Eli Lilly is making even more doses of Zepbound cheaper

Quartz
·
25 Feb

Lilly launches additional Zepbound vial doses and offers new savings for self-pay patients

PR Newswire
·
25 Feb

Lilly launches higher dose vials of weight-loss drug for $150 less than injector pen

Reuters
·
25 Feb

Lilly: Lowering Zepbound Vial Price of 2.5 Mg Dose to $349/Month, of 5 Mg Dose to $499/Month

THOMSON REUTERS
·
25 Feb

Form 4 | Eli Lilly Director Lilly Endowment Inc. sold 90,945 Shares.

SEC Track
·
25 Feb

Major Shareholder Sells Millions in Eli Lilly Stock!

TIPRANKS
·
25 Feb

Here is Why Novo Nordisk A/S (NVO) is Among the Most Oversold Pharma Stocks to Buy According to Analysts

Insider Monkey
·
25 Feb

Citi Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
24 Feb

What To Expect From Supernus Pharmaceuticals’s (SUPN) Q4 Earnings

StockStory
·
24 Feb

Elanco (ELAN) Q4 Earnings Report Preview: What To Look For

StockStory
·
24 Feb